Skip to main content
. 2020 Dec 27;1229:129829. doi: 10.1016/j.molstruc.2020.129829

Table 2.

DPPH activity of synthesized compounds.

Comps Concentrations (µg/mL)
25 50 75 100 IC50
3a 32.65 ± 0.26 45.78 ± 1.18 57.75 ± .0.21 60.02 ± 0.78 9.05+0.86
3b 30.62 ± 0.53 50.12 ± 1.17 53.52 ± 0.51 58.35 ± 0.79 9.32 ± 0.92
3c 35.12 ± 1.47 54.56 ± 1.18 63.45 ± 1.18 64.23 ± .1.09 8.57 ± 0.79
3d 43.25 ± 0.71 52.63 ± 1.06 62.13 ± 1.02 61.18 ± 1.62 8.45 ± 0.65
4a 40.89 ± 1.12 65.02 ± 1.24 68.86 ± 1.17 70.05 ± 1.98 9.97 ± 0.24
4b 35.32 ± 1.43 36.55 ± 0.84 50.45 ± 1.01 52.85 ± 1.03 8.50 ± 0.54
4c 30.36 ± 1.01 52.42 ± 1.27 55.82 ± 1.18 64.46 ± 1.25 9.23 ± 0.49
4d 35.21 ± 0.41 42.18 ± 1.02 54.05 ± 1.65 59.28 ± 1.86 8.34 ± 0.69
5a 38.67 ± 0.51 50.21 ± 0.25 51.65 ± 1.25 62.13 ± 1.33 8.01 ± 0.88
5b 40.12 ± 0.74 48.56 ± 0.61 60.18 ± 0.69 66.54 ± 1.47 9.44 ± 0.82
5c 73.25 ± 1.02 76.68 ± 1.25 88.42 ± 1.57 82.78 ± 0.32 5.78 ± 0.35
5d 67.12 ± 1.22 79.02 ± 1.07 80.92 ± 0.25 81.59 ± 1.02 7.10 ± 0.99
5e 36.42 ± 0.91 49.48 ± 0.24 50.92 ± 0.94 62.25 ± 1.21 8.13 ± 0.24
5f 34.47 ± 1.01 50.32 ± .0.68 59.15 ± 0.87 58.55 ± 1.08 9.41 ± 0.27
5g 52.89 ± 1.04 62.14 ± 1.15 74.91 ± 0.61 80.72 ± 0.97 7.88 ± 0.93
5h 57.47 ± 1.54 62.52 ± 1.54 69.24 ± 1.05 78.64 ± 1.38 8.61 ± 0.19
6a 39.28 ± 0.57 56.02 ± 0.84 69.86 ± 1.29 72.05 ± 1.43 8.71 ± 0.37
6b 46.68 ± 0.24 50.02 ± 1.37 57.71 ± 1.71 58.59 ± 1.87 8.93 ± 0.22
6c 35.12 ± 1.03 43.56 ± 1.44 59.18 ± 1.05 62.34 ± 1.97 8.03 ± 0.78
6d 38.28 ± 1.24 48.19 ± 1.02 56.82 ± 0.50 62.12 ± 1.26 8.96 ± 0.29
6e 35.35 ± 1.07 47.25 ± 1.25 56.82 ± 1.04 65.25 ± 1.03 8.13 ± 0.68
6f 41.42 ± .0.14 55.48 ± 0.85 53.92 ± 1.38 61.01 ± 1.05 9.19 ± 0.57
6g 70.68 ± 0.72 79.78 ± 1.00 80.86 ± 0.25 82.88 ± 0.80 6.96 ± 0.79
6h 42.12 ± 0.54 58.96 ± 0.97 66.19 ± 0.85 68.94 ± 0.83 9.46 ± 0.94
BHA 70.47 ± 0.28 85.52 ± 0.68 90.51 ± 0.04 92.64 ± 0.84 5.77 ± 0.76